Observational studyBreast (Edinburgh, Scotland)2023

Trastuzumab emtansine vs lapatinib and capecitabine in HER2-positive metastatic breast cancer brain metastases: A real-world study.

Thibaut Sanglier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.